India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...

India's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disru...

Indian companies are gearing up to produce ingredients for generic weight-loss drugs. Novo Nordisk's patents are expiring soon. Dr Reddy's ...

India's leading drug makers, through the Indian Pharmaceutical Alliance, have petitioned the Supreme Court to enable police and drug inspec...

The USFDA had inspected the Mandideep Unit-1 facility in Madhya Pradesh from November 14, 2022, to November 23, 2022, the Mumbai-based drug...

Themis had launched inosine pranobex under brand name Viralex in June this year. Despite the drug not figuring in the government's Covid tr...

It is scientifically tested and contains 100 per cent ayurvedic natural ingredients including ashwagandha, shatavari and shilajit that boos...

China initiated protocols on Tuesday to recall fake rabies vaccines sold in other countries and regions amid the recent vaccine scandal.

Around 21 lakh people are estimated to be living with HIV in India but only 14 lakh are known cases, according to the health ministry.

In India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.

Increased cost of production and other European economy related constraints had led to several local drug makers shutting down their unviab...

Laurus is a maker of active pharma ingredients for oncology and anti-retroviral drugs apart from specialty ingredients for nutraceutical in...

Drug-maker Jubilant Life Sciences today announced a price increase of 18 per cent for Niacin feed-grade, with immediate effect.

Reacting to the news, shares of the drug maker plunged as much as 2.3 per cent in trade on the BSE, but recouped early morning losses quick...

The risk of India’s generic drugs being labelled counterfeit under the new definition proposed by WHO has receded, a government representat...

Drug maker Granules India is looking for acquisitions or partnerships in China, Greece, Malta and South Africa to expand capacity and boost...